Copyright/Patent/Trademark
Issue Code: CPT
🤖
AI Overview
Copyright/Patent/Trademark is one of the 79 issue categories tracked under the Lobbying Disclosure Act. With $383.9M in total lobbying spend across 13.0K filings, it ranks among the significantly lobbied policy areas in Washington. The money flowing into this issue reflects how much is at stake for the industries involved.
$383.9M
Total Lobbying Spend
13.0K
Filings
50
Top Clients
Spending by Year
| Year | Spending | Filings |
|---|---|---|
| 2018 | $43.0M | 1,655 |
| 2019 | $48.4M | 1,647 |
| 2020 | $42.8M | 1,636 |
| 2021 | $47.2M | 1,526 |
| 2022 | $53.7M | 1,771 |
| 2023 | $52.6M | 1,691 |
| 2024 | $48.0M | 1,487 |
| 2025 | $48.1M | 1,588 |
Biggest Spenders
Top Firms
Covington & Burling LLP$49.8M
Acg Advocacy$20.0M
Marla Grossman LLC$9.5M
Nvg, LLC$8.5M
Tiber Creek Group$7.9M
Forbes-tate$7.7M
What They Lobby For
- Raising Canndescent's profile in Washington, DC with federal decision makers; intellectual property issues before the US Patent and Trademark Office; promoting Canndescent's research and development o
- PTAB. Patent and Trademark Office
- Healthcare and access issues/IP Protection/Trade
- Promote efficient government procurement policy innovation via transparent and robust data analytics and IT modernization (H.R. 4887); encourage innovation and support intellectual property protection
- Policy and oversight related to the generic pharmaceutical industry.
- Cybersecurity issues. Internet of Things.
- CREATES Act, patents issues related to generics, FDA review and approval of complex generics, CMS regulation of biosimilars, Medicaid generics regulation, Hatch-Waxman Act
- Music licensing, including H.R. 4706, the "Music Modernization Act of 2017."
- Outreach in connection with the Stolichnaya vodka brand in light of ongoing U.S. trademark litigation. Outreach related to the report submitted to Congress by the Department of Treasury Pursuant to s
- Issues relating to the Patent Reform Act
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.